Abstract
To evaluate the hypothesis that the proinflammatory cytokines IL-1, IL-6, and tumor necrosis factor-α might be the link between prenatal intrauterine infection (IUI) and neonatal brain damage, the authors review the relevant epidemiologic and cytokine literature. Maternal IUI appears to increase the risk of preterm delivery, which in turn is associated with an increased risk of intraventricular hemorrhage, neonatal white matter damage, and subsequent cerebral palsy. IL-1, IL-6, and TNF-α have been found associated with IUI, preterm birth, neonatal infections, and neonatal brain damage. Unifying models not only postulate the presence of cytokines in the three relevant maternal/fetal compartments (uterus, fetal circulation, and fetal brain) and the ability of the cytokines to cross boundaries (placenta and blood-brain barrier) between these compartments, but also postulate how proinflammatory cytokines might lead to IVH and neonatal white matter damage during prenatal maternal infection. Interrupting the proinflammatory cytokine cascade might prevent later disability in those born near the end of the second trimester.
Similar content being viewed by others
Main
The interrelationships among maternal (prenatal) infection, preterm birth, and neonatal brain damage are incompletely understood. In this review we offer one scheme and suggest how maternal IUI, neonatal IVH, PVL, and cerebral palsy might be related. We place special emphasis on the relation between IVH and PVL, which are traditionally viewed as two distinct disease entities, and present evidence for the contrary.
In the epidemiology section, we discuss the observations that IUI, IVH, PVL, and cerebral palsy are much more common among infants born near the end of the second trimester than among their gestationally older peers. In the cytokine section, we review the recent clinical and basic science literature to support our hypothesis that a web of mediators of inflammatory responses accounts for many of these relationships.
EPIDEMIOLOGY
Preterm birth is defined as delivery before the completion of 37 wk of gestation(1). In this article, however, we focus on the increased risk of brain damage among the very preterm, i.e. those born before 32 wk of gestation, and/or those with a VLBW (<1500 g). In the United States, 1-2% of liveborn babies fall into these categories(2, 3).
Infection. Preterm labor and prelabor rupture of membranes, but not preeclampsia/pregnancy-induced hypertension, appear to be related to maternal infection(4–7). For example, chorioamnionitis is associated with a 3-fold increased risk of delivery before term with intact membranes and a 4-fold increased risk of preterm birth due to prelabor rupture of membranes(8).
Bacterial vaginosis at 23-26 wk of gestation appears to increase a woman's risk of preterm delivery by 50%(9). A randomized trial comparing women with bacterial vaginosis, who received antibiotic treatment, with untreated peers resulted in a 27% decrease of preterm delivery(10).
We prefer the use of the term “intrauterine infection” (IUI) to the widely used “intraamniotic infection” to emphasize that the amniotic fluid need not be involved in upper genital tract infection(11), and to include the possibility of prepregnancy origin of the infection(12). When referring to the work of others, however, we tend to use the term used in the original article.
IVH. IVH occurs in up to 40% of infants below 35 wk or <1500 g as compared with 3-4% of babies with a gestational age >37 wk(13). About 5% of infants with apparently isolated IVH later develop cerebral palsy(14).
White matter damage. Neonatal white matter damage, which has been subdivided into periventricular hemorrhagic infarction and PVL on the basis of neuropathologic findings(15), is presumably more important than IVH in predicting long-term developmental disability(16). We tend to restrict ourselves to the description of hyper- and hypoechoic images demonstrable by ultrasound in vivo. We do so because the widely used ultrasound patterns of periventricular hemorrhagic infarction and PVL account for only a portion of neonatal white matter damage observed in large populations of infants (our unpublished observation). About 60% of infants with PVL, defined sonographically as a“hypoechoic” or “echolucent” image in the cerebral white matter, later develop cerebral palsy(14, 16).
IUI and IVH. Although gestational age is known to be a major predictor of IVH occurrence(13), the exact mechanisms leading to the occurrence of blood in the baby's ventricles are still unknown. Preterm infants whose amnion is acutely inflamed are at a 3-4-fold greater risk than are their peers of developing IVH(17–19). Receipt of prophylactic antibiotic by the gravida after prelabor rupture of membranes has been inconsistently followed by reduced risk of IVH in her offspring(20, 21).
Our own findings indicate that, among VLBW infants, those whose placenta had any inflammation were at a 2.6-fold increased risk of IVH (26%versus 12%) (Table 1). An additional intriguing finding is that this increased risk is most prominent in the subgroup of infants born after a short duration of ruptured membranes (data not shown). This suggests that a preexisting infection of the mother before birth is more important in predicting IVH risk than the perinatal ascending infection that often accompanies “long” duration of ruptured fetal membranes (our unpublished observation).
This relationship between IUI and IVH might be due to associations with a common confounder variable. Perhaps the most obvious candidates for confounding our perception of the IUI/IVH relationship are low gestational age, labor, and vaginal delivery. However, when we adjust for these potential confounders, the IUI-IVH relationship persists.
IUI and PVL. In our sample, those infants whose placental membranes were inflamed were at 60-70% increased risk of PVL and ventriculomegaly (Table 1). These findings are in agreement with the results of others. A positive placenta culture or chorioamnionitis was present in the fully 54% of infants <36 wk of gestation who developed echolucencies of the white matter within 3 d after birth(22). VLBW infants with periventricular echodensities, which often precede PVL, were exposed to chorioamnionitis 2.6 times more often than their controls without echodensities(23). Ultrasonographic evidence of “cystic PVL” was present in 9% of a sample of 753 preterm infants born between 24 and 32 wk of gestation, whereas this percentage was 19% in the subset of babies whose mothers had IUI and even higher (22%) among those whose mothers had IUI and premature rupture of membranes(24). The finding that acute appendicitis is associated with both preterm labor and IVH or PVL(25) suggests that even extrauterine, intraabdominal infections can be part of the cascade of events linking infection, labor, and neonatal brain injury.
IVH and PVL. Among preterm or VLBW infants, IVH is associated with an increased risk of PVL. In a cohort of 124 neonates with a birth weight<1250 g, intraparenchymal echodensities in the periventricular region were found only among those infants who also had IVH(26). Grade III or IV IVH was six times more common among infants who had signs of periventricular white matter damage by 3 d after birth, than among gestational age peers who had no white matter abnormalities(22). Among infants with an abnormal periventricular echogenicity, those who had IVH were three times more likely to develop so-called periventricular“cysts” than those who did not have IVH(27). Fully 75% of the brains of infants who died after an in vivo diagnosis of IVH had PVL on histologic postmortem examination(28). In our sample, the prevalence of PVL was 1-2% among infants without IVH, 5-fold higher among infants with IVH only, and 24 times higher among those who had both IVH and ventriculomegaly(Table 2). Once an infant has IVH, her risk of PVL is elevated to the same extent regardless of whether or not her placental membranes were inflamed.
PVL and cerebral palsy. Children with spastic cerebral palsy who die have neuropathologic changes in the white matter consistent with PVL in the neonatal period (i.e. prominent gliosis and paucity of cerebral white matter)(29). Between 60 and 100% of preterm infants with PVL subsequently develop cerebral palsy(14, 16). Later in childhood, approximately 90% of those born preterm who develop spastic cerebral palsy have magnetic resonance images of the white matter viewed as sequelae of neonatal PVL(30, 31).
IUI and cerebral palsy. To support the scenario laid out in the preceding paragraphs, we need documentation that, among children born preterm, those who develop cerebral palsy are more likely than their peers to have been exposed to maternal IUI. Such an association was found in two recent case-control studies. Chorioamnionitis was diagnosed in the mothers of 17% of preterm infants who subsequently developed cerebral palsy in contrast to only 3% among mothers of preterm controls (odds ratio 4.2, 95% confidence interval 1.4-12)(32). In the other study of VLBW infants, those whose mother had chorionitis were at increased risk of cerebral palsy (odds ratio 4.3; 95% confidence interval 1.1-13)(33).
CYTOKINES
Major advances in our understanding of the biology of preterm birth have been made by the study of the cytokine network of mediators of uterine contractions. Although some reviewers of the topic do not believe in the importance of maternal infection as an initiator of preterm delivery(34), others find support for the hypothesis that intraamniotic infection(6, 35, 36) or, even earlier, IUI(12) precede or accompany an appreciable proportion of preterm births.
Adinolfi(37) proposed that cytokines produced by the immune system during the course of maternal infection are harmful to the developing brain of the unborn infant. Leviton(38) extended this hypothesis, suggesting that cytokines such as TNF-α produced in response to IUI contribute to both preterm birth and periventricular white matter damage. Indeed, women who were found to have increased levels of TNF-α or IL-6 in cervicovaginal swabs were at a 3-fold increased risk of delivering preterm(39). Compared with women who gave birth at term, those who delivered at or before 34 wk of gestation were much more likely to have elevated amniotic fluid levels of TNF-α, IL-6, and prostaglandin E2, and to have histologic chorioamnionitis(40). Most recently, IL-6 levels were significantly elevated in the amniotic fluid of women whose infants later developed IVH or PVL(41). IL-6 levels were also elevated in the umbilical cord blood of neonates who developed a persistent echodensity or echolucency(42).
The somewhat simplistic, but helpful model of the “maternofetal unit” may be an approach to the problem of how IUI, preterm birth, IVH, and PVL may be linked. The uterus, the fetal circulation, and the fetal brain can be viewed as three compartments with the placenta representing the boundary between the mother and fetus, and the fetus' BBB as the boundary between the systemic circulation and the brain (Fig. 1).
When proposing a scenario of how cytokines may be the mediators between the mother's infection and brain damage in her newborn, one has to find support for the following hypotheses: 1) cytokines are present during infection in all three compartments (uterus, fetal circulation, and brain); 2) cytokines are present in, or can cross, the boundaries (placenta and BBB) between the compartments; 3) cytokines contribute to the occurrence of IVH, and 4) cytokines are involved in the induction of the white matter damage usually described as PVL. In the remainder of this review we emphasize the possible role of the proinflammatory cytokines IL-1β, TNF-α, and IL-6.
Cytokines are present during infection in all three compartments(i.e. uterus, fetal circulation, and brain). IL-6 first appears in amniotic fluid during the second trimester, and increases at term (with the onset of labor) as do TNF and IL-1, suggesting a role for these cytokines in normal labor(43). The role of the cytokine cascade in the induction of preterm labor has been discussed in detail by others(6, 36, 44).
TNF-α and/or IL-6 have been found elevated in amniotic fluid of pregnant women with chorioamnionitis(40, 45–47), even among women with intact membranes(48), but only IL-6 was elevated in both maternal and fetal blood(47). IL-6 levels are higher in the cord blood of term newborns whose mothers had clinical(49) and histologic chorioamnionitis(50) than in their unexposed peers. After stimulation with lipopolysaccharide and concanavalin A(51) or IL-1(52), both neonatal and adult mononuclear cells produce IL-6. The blood serum concentration of IL-6 is higher in infants with confirmed prenatal infections than in those with infections acquired after birth(53), and elevated serum TNF-α levels are associated with Gram-negative sepsis in both term(54) and preterm newborns(55). Recently, IL-6 blood levels of ≥100 pg/mL before the 12th h of life were proposed as a better marker of neonatal infection than the usually obtained C-reactive protein(56).
Finally, proinflammatory cytokines and their respective receptors are expressed in the brain (for review, seeRefs. 57 and 58). Lipopolysaccharide-stimulated microglia produce large amounts of IL-1β, TNF-α, and IL-6. In murine models, these effects can be blocked by pentoxifylline (blocks TNF-α and IL-1) and dexamethasone(blocks TNF-α and IL-6)(59). IL-1β-production by microglia is also induced by TNF-α and IL-1β itself. In turn, IL-1β induces the production by fetal astrocytes of IL-1β, TNF-α, and IL-6. Thus, as suggested by Lee et al.(60), IL-1 seems to play a key role as a mediator between fetal microglia and astrocytes in the presence of lipopolysaccharide.
Cytokines are present in or may cross the boundaries (placenta and BBB) between the compartments. Although placental cells produce IL-6 and other proinflammatory cytokines(61–64), the evidence that these cytokines cross the placenta remains unclear(65). On the other hand, cells in the placental villi and chorion [for an overview, see Mitchell et al.(66)] and umbilical veins(67) are also a source of proinflammatory cytokines, thereby allowing them access to the fetal circulation without requiring maternally derived cytokines to cross the placenta. The amounts of proinflammatory cytokines produced by cultured fetal amniochorionic membranes in response to lipopolysaccharide challenge are comparable with those found in the amniotic fluid after microbial invasion(68), suggesting intraplacental production rather than cross-placental transport (Fig. 1) as a relevant mode of cytokine occurrence.
In the fetus, the BBB is much less effective than in children and adults(69). Nevertheless, IL-1α(70), IL-1β(71), IL-6(72), and TNF-α(73) cross the intact adult murine BBB. More important for our scenario, however, are the cytokine-BBB interactions that might lead to BBB damage (see below).
Cytokines may contribute to the occurrence of IVH. IVH is thought to originate mainly from the blood vessels in the germinal matrix. During fetal development, these vessels grow rapidly and may be prone to a variety of damaging mechanisms, which may, in part, be mediated by cytokines.
Access. Cytokines are present in the fetal and neonatal circulation(42, 49, 50, 53–56, 74) and by this means might damage the endothelium of germinal matrix vessels. A second way cytokines can reach the germinal matrix region is via cerebrospinal fluid. IL-1β and TNF-α have been detected in the cerebrospinal fluid of newborns with Gram-negative meningitis(75), and IL-6 concentrations are elevated in the cerebrospinal fluid of children with bacterial meningitis(76). Choroid plexus ependymal cells are capable of TNF-α production in vivo and in vitro after endotoxin exposure(77). Once in the cerebrospinal fluid, cytokines might attack the developing germinal matrix vessels from their outside.
A third way cytokines can gain access to germinal matrix blood vessels is from adjacent microglia and/or astrocytes(60, 78). Astrocytes are capable of producing cytokines and are in close connection with endothelial cells in forming the BBB. Parenchymal microglia, also capable of producing cytokines, extend their processes into the ependymal layer of the third ventricle(79).
Mechanisms. Usually, the BBB protects the brain parenchyma from exposure to protein leakage from blood vessels. The BBB is characterized by tight junctions between the endothelial cells of most brain blood vessels, except in some areas close to the third ventricle, the so-called circumventricular organs(80, 81). However, early in gestation the endothelium of the germinal matrix has neither fenestrations(such as that of the circumventricular organs) nor tight junctions, but instead has so-called “strap junctions”(82). This strap-junction ependyma is replaced at about mid-gestation by a“mature looking ependymal layer”(83). This period of physiologic BBB change could be a time of increased vulnerability of the fetus' BBB to cytokine-induced alterations.
In adult rats, intracisternal administration of IL-1β and TNF-α result in a reversible, dose-dependent increase of BBB permeability(84), as do intracerebral injection of TNF-α(85) and systemic administration of IL-2 and IL-6(86). The BBB does not develop in transgenic mice overexpressing IL-6(87). In an observational study on human patients, however, intrathecal TNF-α levels, but not those of IL-1β, correlated with a measure of BBB damage(88). On the other hand, when administered systemically via intracarotid injection to rats, TNF-α resulted in an increase of the BBB(86).
Indomethacin appears to reduce the risk of IVH(89). One explanation for this is that indomethacin enhances maturation(90). Another is that it reduces (or prevents) post BBB injury permeability increases(91). A third is that indomethacin abolishes the increased BBB permeability induced by proinflammatory cytokines(92).
One role of cytokines is the mediation of intravascular leukocyte adhesion and transendothelial migration. TNF-α-treated astrocytes express the mRNA for adhesion molecules E-selectin, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1(93), which“might guide inflammatory leukocytes into and through the brain parenchyma”(94). Another cytokine presumably involved in the chemoattraction of mononuclear leukocytes in the CNS during inflammation is astrocyte-produced interferon-γ-inducible protein 10(95), a chemokine whose expression is induced by TNF-α(96) and which has been shown to inhibit angiogenesis(97, 98). Most important for our scheme employing cytokines to explain the occurrence of IVH during maternal infection is that this process of adhesion of leukocytes to the endothelium may be followed by endothelial cell damage(99, 100). If TNF-α is able to induce hemorrhagic necrosis in highly vascularized and rapidly growing mouse tumors (one of the first functions observed for this cytokine which gave it its name)(101), could it similarly damage the fetal germinal matrix? In another context, brain hemorrhages occurring during the course of cerebral malaria have readily been related to TNF-α mediated cerebrovascular damage(102).
Cytokines can have profound effects on the coagulation system(103). TNF interacts with IL-1 in inducing procoagulant activity in the vascular endothelium(104), prostacyclin synthesis(105), and expression of plasminogen-activator-inhibitor, the main inhibitor of fibrinolysis(106–108). These observations relate to the clinical finding that IL-1β, IL-6, and TNF-α measurements were significantly elevated in adult patients with disseminated intravascular coagulation(109). Blood platelets are activated, and their aggregation is enhanced by IL-6(110), whereas TNF-α induces platelet-activating factor release(111). Platelet-activating factor can lead to vasoconstriction(112) as might IL-6 during subarachnoid hemorrhage(113), which can occur as a complication of CNS infection(114).
In summary, cytokines are able to mediate BBB alteration or even breakdown, intravascular cell adhesion, coagulation and/or thrombosis, and vasoconstriction in the presence of infection. These mechanisms may in turn lead to endothelial damage and subsequent hemorrhage from germinal matrix vessels into the ventricles of the preterm newborn.
Cytokines may be involved in the induction of white matter damage. IVH might contribute to white matter damage via ventriculomegaly, which compresses periventricular capillaries, thereby leading to ischemia in the white matter(115). Another mechanism might be periventricular hemorrhagic venous infarction, although its“pathogenesis... is not entirely established”(15). Furthermore, both IVH and the multifocal or focal hemorrhages in the white matter may be expressions of a diffuse hemorrhagic tendency, as seen in our sample (F. Gilles, J. Golden, and R. Rudelli, personal observation).
How may cytokines in the intraventricular blood contribute to periventricular white matter damage? First, because an ependymal layer does not line the lateral ventricles until about 22 wk of gestation(116), there might be no physiologic barrier protecting the periventricular parenchyma from potentially harmful cytokines in the cerebrospinal fluid of extremely preterm babies.
Second, potentially harmful molecules, either produced in the ventricle(e.g. in the choroid plexus) or present in the intraventricular hemorrhage, might enter the periventricular parenchyma from the ventricular lumen by passing the intact ependyma on the trans-cellular level. One of the tasks of the normal fetal ependyma, beside many others, is the exchange of fluid, ions, and small molecules between the intraventricular space and the surrounding tissue(116). We still do not know if intraventricular cytokines pass through the ventricular ependyma to reach the periventricular white matter. However, because cytokines are able to cross the intact BBB(70–73), and the BBB shares some structural characteristics with the ventricular ependyma (e.g. tight junctions), it seems plausible that cytokines can pass through the intact ventricular ependyma once it is established.
Third, hemorrhagic cerebrospinal fluid may leave the ventricle after interruption of ependymal continuity. The integrity of the ventricular ependyma may be interrupted by mechanical trauma (e.g. stretching in posthemorrhagic ventricular dilation), infarction, or inflammation(117). The resulting atrophy of the ependymal cells and discontinuity of the ependymal lining (gaps) may expose the parenchyma to“cerebrospinal fluid edema”(118) which, in our scenario, may carry blood and cytokines. What may be found in the subventricular brain parenchyma in cases of ependymal injury are an abundance of glial cells and, in the presence of infection, macrophages(117). Macrophages and glial cells are not only producers of cytokines, but are also histologic characteristics of neonatal white matter damage(119).
Fourth, the inflammatory response mounted by the ependyma after IVH(120) might include the production of TNF-α(77) and glial fibrillary acidic protein(116, 121–123). Glial fibrillary acidic protein is expressed by glial cells and in the white matter of infants with histologic evidence of PVL(124).
Once in the parenchyma, how may cytokines cause brain tissue damage? In the kitten, intraperitoneal injection of lipopolysaccharide, a strong stimulator of cytokine production, was followed by astrogliosis, cystic necrosis, and deposits of eosinophilic or mineralized debris in the white matter(125). Now there is evidence that cytokines may be mediators of neuronal and white matter tissue injury. Microinjections of IL-1, IL-2, IL-6, and TNF-α into neonatal murine cortex enhance the extensive astroglial reactivity that follows a scissors stab wound(126). Recently, microglial expression of TNF-α immunoreactivity was found in the white matter of infants with PVL associated lesions twice as commonly as in the white matter of those without such lesions(127). This observation alone does not explain how tissue destruction may occur, but supports the findings of others that fetal microglia are capable of TNF-α release and TNF-α mRNA expression(60, 128). Cytokines such as TNF-α (or IL-6) might play a role in damaging developing white matter by 1) leading to hypotension, 2) inducing blood vessel obstruction via intravascular coagulation, 3) adversively influencing oligodendrocytes, astrocytes, and myelin, or 4) by inducing the production of other cytokines such as platelet activating factor, which in turn has cell damaging properties [for review, see Leviton(38)].
Multivariability. Although we have emphasized the cytotoxic effects of cytokines, some relationships between cytokines and other mediators of brain damage in the fetus and newborn deserve mention. IL-1 release by human fetal microglia leads to IL-6 and TNF production by astrocytes(60). Fetal astrocytes also produce nitric oxide upon stimulation with IL-1, and this process is enhanced by addition of interferon-γ or TNF-α(129). Maximal injury to human fetal brain cell cultures containing neurons and glial cells occurred after the addition of IL-1β plus TNF-α(130). This synergism of TNF-α and IL-1β has also been observed in animal models of septic shock(131) and can be partially blocked by a nitric oxide synthase inhibitor (45% reduction of damage) and by N- methyl-D-aspartate receptor antagonists (55%)(130). This gives rise to the speculation that cytokines in the developing brain play a role in the mediation of neurotoxicity by nitric oxide(59, 129, 132) and excitatory amino acids (for review, seeRefs. 133 and 134).
In the newborn rat model of so-called “hypoxia-ischemia,” IL-1 and IL-6 mRNA are expressed in brain tissue(135). Human umbilical vein endothelial monolayers produce significantly more IL-1 (α and β) and IL-6 when exposed to hypoxia/reoxygenation than when incubated in room air(66). The ability of superoxide dismutase and glutathione peroxidase to prevent this effect suggests a role for oxygen-derived free radicals in the synthesis of cytokines in this setting.
We have only addressed mechanisms involving cytokines. Most certainly, cytokines are only one piece in the multivariable puzzle of neonatal white matter damage. However, this does not diminish their importance.
CONCLUSION
The epidemiologic evidence of an association between IUI in the mother and both IVH and white matter damage in her newborn, at least in part, can be explained by the biologic effects of proinflammatory cytokines. Further etiologic studies employing the cytokine network are needed to develop strategies intended to prevent some of the disabilities associated with very preterm delivery. Such strategies should emphasize prevention and treatment of IUI to reduce the risk of very preterm delivery(10, 12), although anticytokine strategies deserve consideration(136–138).
Abbreviations
- BBB:
-
blood-brain barrier
- IUI:
-
intrauterine infection
- IVH:
-
intraventricular hemorrhage
- PVL:
-
periventricular leukomalacia
- TNF:
-
tumor necrosis factor
- VLBW:
-
very low birth weight
References
World Health Organization 1977 International classification of diseases. Manual of the international classification of diseases, injuries, and causes of death, Vol 1. WHO, Geneva, p 764
Berkowitz GS, Papiernik E 1993 Epidemiology of preterm birth. Epidemiol Rev 15: 414–443.
Lee KS, Khoshnood B, Hsieh HL, Kim BI, Schreiber MD, Mittendorf R 1995 Which birth weight groups contributed most to the overall reduction in the neonatal mortality rate in the United States from 1960 to 1986?. Paediatr Perinat Epidemiol 9: 420–430.
Romero R, Lockwood C, Oyarzun E, Hobbins JC 1988 Toxemia: new concepts in an old disease. Semin Perinatol 12: 302–323.
Broughton Pipkin F 1995 The hypertensive disorders of pregnancy. BMJ 311: 609–613.
Gomez R, Hezzi F, Romero R, Muñoz H, Tolosa JE, Rojas I 1995 Premature Labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 22: 281–342.
Guinn DA, Goldenberg RL, Hauth JC, Andrews WW, Thom E, Romero R 1995 Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor. Am J Obstet Gynecol 173: 1310–1315.
Seo K, McGregor JA, French JI 1992 Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 79: 75–80.
Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin Dh, Cotch MF, Edelman R, Pastorek JG, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA, for the Vaginal Infections and Prematurity Study Group 1995 Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333: 1737–1742.
Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL 1995 Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333: 1732–1736.
Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH 1995 Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 173: 606–612.
Goldenberg RL, Andrews WW 1996 Editorial: Intrauterine infection and why preterm prevention programs have failed. Am J Public Health 86: 781–783.
Paneth N, Pinto-Martin J 1990 The epidemiology of germinal matrix/intraventricular hemorrhage. In: Kiely M (ed) Reproductive and Perinatal Epidemiology. CRC Press, Boca Raton, FL, pp 371–399.
Paneth N, Rudelli R, Kazam E, Monte W 1994 Brain Damage in the Preterm Infant. MacKeith Press, London, 171–185.
Volpe JJ 1992 The epidemiology of germinal matrix/intraventricular hemorrhage. Biol Neonate 62: 231–242.
Leviton A, Paneth N 1990 White matter damage in preterm newborns-an epidemiologic perspective. Early Hum Dev 24: 1–22.
Morales WJ 1987 The effect of chorioamnionitis on the developmental outcome of preterm infants at one year. Obstet Gynecol 70: 183–186.
Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC 1995 Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 172: 960–970.
Salafia CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, Vintzileos AM 1995 Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 wk gestation. Am J Perinatol 12: 429–436.
Mercer BM, Arheart KL 1995 Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 346: 1271–1279.
Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A, Schemper M 1996 Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 174: 589–597.
Bejar R, Wozniak P, Allard M, Benirschke K, Vaucher Y, Coen R, Berry C, Schragg P, Villegas I, Resnik R 1988 Antenatal origin of neurologic damage in newborn infants. Am J Obstet Gynecol 159: 357–363.
Kothadia JM, O'Shea TM, Del Paggio D, Dillard RG 1994 Prenatal risk factors for periventricular echodensity in very low birth weight neonates. Paediatr Perinat Epidemiol 8:A7.
Zupan V, Gonzalez P, Lacaze-Masmonteil T, Boithias C, D'Allest AM, Dehan M, Gabilan JC 1996 Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 38: 1061–1067.
Mays J, Verma U, Klein S, Tejani N 1995 Acute appendicitis in pregnancy and the occurrence of major intraventricular hemorrhage and periventricular leukomalacia. Obstet Gynecol 86: 650–652.
Perlman JM, Rollins N, Burns D, Risser R 1993 Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birthweight neonate. Pediatrics 91: 474–480.
Trounce JQ, Rutter N, Levene MI 1986 Periventricular leucomalacia and intraventricular haemorrhage in the preterm neonate. Arch Dis Child 61: 1196–1202.
Armstrong DL, Sauls CD, Goddard-Finegold J 1987 Neuropathologic findings in short-term survivors of intraventricular hemorrhage. Am J Dis Child 141: 617–621.
Dambska M, Laure-Kamionowska M, Schmidt-Sidor B 1989 Early and late neuropathological changes in perinatal white matter damage. J Child Neurol 4: 291–298.
Yokochi K, Aiba K, Horie M, Inukai K, Fujimoto S, Kodama M, Kodama K 1991 Magnetic resonance imaging in children with spastic diplegia: correlation with the severity of their motor and mental abnormality. Dev Med Child Neurol 33: 18–25.
Krägeloh-Mann I, Petersen D, Hagberg G, Vollmer B, Hagberg B, Michaelis R 1995 Bilateral spastic cerebral palsy-MRI pathology and origin. Analysis from a representative series of 56 cases. Dev Med Child Neurol 37: 379–397.
Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM 1995 Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 346: 1449–1454.
Grether JK, Nelson KB, Emery ES, Cummins SK 1996 Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J Pediatr 128: 407–414.
MacDonald PC, Casey ML 1996 Preterm birth. Sci Am March/April: 42–51.
Lockwood CJ 1994 Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventive therapies. Curr Opin Obstet Gynecol 6: 7–18.
Mazor M, Cohen J, Romero R, Ghezzi F, Tolosa JE, Gomez R 1995 Cytokines and preterm labor. Fetal Maternal Med Rev 7: 207–233.
Adinolfi M 1993 Infectious diseases in pregnancy, cytokines and neurological impairment: an hypothesis. Dev Med Child Neurol 35: 549–553.
Leviton A 1993 Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?. Dev Med Child Neurol 35: 553–558.
Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, Witkin SS 1994 Detection of tumor necrosis factor-α, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 171: 5–10.
Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA 1993 The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 81: 941–948.
Figueroa R, Martinez E, Sehgal P, Garry D, Patel K, Verma U, Visintainer P, Reale M, Klein S, Tejani N 1996 Elevated amniotic fluid interleukin-6 predicts neonatal periventricular leukomalacia and intraventricular hemorrhage. Am J Obstet Gynecol 174: 330
Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC 1996 Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174: 1433–1440.
Opsjøn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R 1993 Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 169: 397–404.
Mitchell MD, Trautman MS, Dudley DJ 1993 Cytokine networking in the placenta. Placenta 14: 249–275.
Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J 1992 Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 166: 1576–1587.
Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M 1993 Elevation of amniotic fluid interleukin-6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 5: 81–88.
Stallmach T, Hebisch G, Joller-Jemelka HI, Orban P, Schwaller J, Engelmann M 1995 Cytokine production and visualized effects in the feto-maternal unit. Lab Invest 73: 384–392.
Greig PC, Ernest JM, Teot L, Erikson M, Talley R 1993 Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 169: 1035–1044.
Singh B, Merchant P, Walker CR, Kryworuchko M, Diaz-Mitoma F 1996 Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis. Pediatr Res 39: 976–979.
Miyano A, Miyamichi T, Nakayama M, Kitajima H, Shimizu A 1996 Effect of chorioamnionitis on the levels of serum proteins in the cord blood of premature infants. Arch Pathol Lab Med 120: 245–248.
Yachie A, Takano N, Yokoi T, Kato K, Kasahara Y, Miyawaki T, Taniguchi N 1990 The capability of neonatal leukocytes to produce IL-6 on stimulation assessed by whole blood culture. Pediatr Res 27: 227–233.
Liechty KW, Koenig JM, Mitchell MD, Romero R, Christensen RD 1991 Production of interleukin-6 by fetal and maternal cells in vivo during intraamniotic infection and in vitro after stimulation with interleukin-1. Pediatr Res 29: 1–4.
Drews K, Szczapa J, Zak J, Andrzejewska R, Zak L, Mackiewicz A 1995 Blood serum concentration of C-reactive protein and interleukin-6 in diagnosis of neonatal infection. Ann NY Acad Sci 762: 398–399.
Williams PA, Bohnsack JF, Augustine NH, Drummond WK, Rubens CE, Hill HR 1993 Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr 123: 292–300.
Girardin EP, Berner ME, Grau GE, Suter S, Lacourt G, Paunier L 1990 Serum tumour necrosis factor in newborns at risk for infections. Eur J Pediatr 149: 645–647.
Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U 1996 Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 129: 574–580.
Hopkins SJ, Rothwell NJ 1995 Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 18: 83–88.
Ransohoff RM, Benveniste EN (eds) 1996 Cytokines and the CNS. CRC Press, Boca Raton, FL
Chao CC, Hu S, Close K, Choi CS, Molitor TW, Novick WJ, Peterson PK 1992 Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infect Dis 166: 847–853.
Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW 1993 Cytokine production by human fetal microglia and astrocytes. J Immunol 150: 2659–2667.
Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC 1989 Cachectin/tumor necrosis factor-α in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest 83: 430–436.
Dudley DJ, Chen CL, Branch DW, Hammond E, Mitchell MD 1993 A murine model of preterm labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua. Biol Reprod 48: 33–39.
Kauma SW, Herman K, Wang Y, Walsh SW 1993 Differential mRNA expression and production of interleukin-6 in placental trophoblast and villous core compartments. Am J Reprod Immunol 30: 131–135.
Matsuzaki N, Taniguchi T, Shimoya K, Neki R, Okada T, Saji F, Nakayama M, Suehara N, Tanizawa O 1993 Placental interleukin-6 production is enhanced in intrauterine infection but not in labor. Am J Obstet Gynecol 168: 94–97.
Kent ASH, Sullivan MHF, Sun MY, Zosmer A, Elder MG 1993 Effects of interleukin-6 and tumor necrosis factor-α on prostaglandin production by cultured human fetal membranes. Prostaglandins 46: 351–359.
Mitchell MD, Trautman MS, Donald DJ 1993 Cytokine networking in the placenta. Placenta 14: 249–275.
Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornand J 1992 Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 promotion. Effects on free radical scavengers. Agents Actions 37: 134–139.
Fortunato SJ, Menon RP, Swan KF, Menon R 1996 Inflammatory cytokine (interleukins 1, 6, and 8 and tumor necrosis factor-α) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 174: 1855–1862.
Adinolfi M 1985 The development of the human blood-CSF-brain barrier. Dev Med Child Neurol 27: 532–537.
Banks WA, Kastin AJ, Gutierrez EG 1993 Interleukin-1α in blood has direct access to cortical brain cells. Neurosci Lett 163: 41–44.
Banks WA, Ortiz L, Plotkin SR, Kastin AJ 1991 Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259: 988–996.
Banks WA, Kastin AJ, Gutierrez EG 1994 Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179: 53–56.
Gutierrez EG, Banks WA, Kastin AJ 1993 Murine tumor necrosis factor-α is transported from blood to brain in the mouse. J Neuroimmunol 47: 169–176.
Miller LC, Isa S, LoPreste G, Schaller JG, Dinarello CA 1990 Neonatal interleukin-1β, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatr 117: 961–965.
McCracken GH, Mustafa MM, Ramilo O, Olsen KO, Risser RC 1989 Cerebrospinal fluid interleukin 1-β and tumor necrosis factor concentrations and outcome from neonatal Gram-negative enteric bacillary meningitis. Pediatr Infect Dis J 8: 155–159.
Matsuzono Y, Narita M, Akutsu Y, Togashi T 1995 Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Paediatr 84: 879–883.
Tarlow MJ, Jenkins R, Comis SD, Osborne MP, Stephens S, Stanley P, Crocker J 1993 Ependymal cells of the choroid plexus express tumour necrosis factor-α. Neuropathol Appl Neurobiol 19: 324–328.
Merrill JE 1992 Tumor necrosis factor-α, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14: 1–10.
Van Dam AM, Bauer J, Tilders FJ, Berkenbosch F 1995 Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65: 815–826.
Bartanusz V, Jezova D 1992 The role of some circumventricular organs in hormone action and secretion. Endocr Regul 26: 3–9.
Risau W 1994 Molecular biology of blood-brain barrier ontogenesis and function. Acta Neurochir Suppl 60: 109–112.
Møllgård K, Saunders NR 1986 The development of the human blood-brain and blood-CSF barriers. Neuropathol Appl Neurobiol 12: 337–358.
Møllgård K, Balslev Y, Lauritzen B, Saunders NR 1987 Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: a CSF-brain barrier. J Neurocytol 16: 433–444.
Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM 1991 Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87: 1360–1366.
Wright JL, Merchant RE 1994 Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the rat. J Neurooncol 20: 17–25.
Saija A, Princi P, Lanza M, Scalese M, Aramnejad E, DeSarro A 1995 Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci 56: 775–784.
Brett FM, Mizisin AP, Powell HC, Campbell IL 1995 Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54: 766–775.
Sharief MK, Ciardi M, Thompson EJ 1992 Blood-brain barrier in patients with bacterial meningitis: association with tumor necrosis factor-α but not interleukin-1β. J Infect Dis 166: 350–358.
Ment LR, Oh W, Ehrenkranz RA, Philip AGS, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJW, Katz KH, Schneider KC, Makuch RW 1994 Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93: 543–550.
Ment LR, Stewart WB, Ardito TA, Huang E, Madri JA 1992 Indomethacin promotes germinal matrix microvessel maturation in the newborn beagle pup. Stroke 23: 1132–1137.
Zuckerman SL, Mirro R, Armstead WM, Shibata M, Leffler CW 1992 Indomethacin reduces ischemia-induced alteration of blood-brain barrier transport in piglets. Am J Physiol 266:H2198–H2203.
DeVries HE, Blom-Roosemalen MC, Van Oosten M, De Boer AG, Van Berkel TJ, Breimer DD, Kuiper J 1996 The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64: 37–43.
Hurwitz AA, Lyman WD, Guida MP, Calderon TM, Berman JW 1992 Tumor necrosis factor-α induces adhesion molecule expression on fetal human astrocytes. J Exp Med 176: 1631–1636.
Merrill JE, Benveniste EN 1996 Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19: 331–338.
Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK 1993 Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592–600.
Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA 1993 Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 142: 861–870.
Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ 1995 Interferon-γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 210: 51–57.
Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G 1995 Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182: 155–162.
Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS 1990 Tumor necrosis factor-α/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 171: 2025–2041.
Westlin WF, Gimbrone MA Jr 1993 Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 142: 117–128.
Carswell EA, Old LJ, Kassel FL, Green S, Fiore N, Williamson B 1975 An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3671.
Grau GE, Lou J 1993 TNF in vascular pathology: the importance of plateletendothelium interactions. Res Immunol 144: 355–363.
Esmon CT 1994 Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Clin Haematol 7: 453–468.
Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr 1986 Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterisation and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83: 4533–4537.
Kawakami M, Ishibashi S, Ogawa H, Murase T, Takahu F, Shibata S 1986 Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 141: 482–487.
Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr 1988 Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263: 5797–5809.
Dosne AM, Dubor F, Lutcher F, Parant M, Chedid L 1988 Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat. Thromb Res 51: 115–122.
Van Hinsbergh VWM, Kooistra T, Vanderberg EA, Princer HMG, Fiers W, Emeis JJ 1988 Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72: 1467–1473.
Wada H, Tanigawa M, Wakita Y, Nakase T, Minamikawa K, Kaneko T, Ohiwa M, Kageyama S, Kobayashi T, Noguchi T, Deguchi K, Shirakawa S 1993 Increased plasma level of interleukin-6 in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 4: 583–590.
Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E 1994 Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost 72: 302–308.
Camussi G, Bussolino F, Salvidio G, Baglioni C 1987 Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet activating factor. J Exp Med 166: 1390–1404.
Armstead WM, Pourcyrous M, Mirro R, Leffler CW, Busija DW 1988 Platelet activating factor: a potent constrictor of cerebral arteriole in newborn pigs. Circ Res 62: 1–7.
Kikuchi T, Okuda Y, Kaito N, Abe T 1995 Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 17: 106–108.
Rinkel GJE, VanGijn J, Wijdicks EFM 1993 Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. Stroke 24: 1403–1409.
DelBigio MR, Bruni JE 1988 Changes in periventricular vasculature of rabbit brain following induction of hydrocephalus and after shunting. J Neurosurg 69: 115–120.
Sarnat HB 1992 Role of human fetal ependyma. Pediatr Neurol 8: 163–178.
Sarnat HB 1995 Ependymal reactions to injury. A review. J Neuropathol Exp Neurol 54: 1–15.
Weller RO, Mitchell J 1980 Cerebrospinal fluid edema and its sequela in hydrocephalus. Adv Neurol 28: 111–123.
Paneth N, Rudelli R, Kazam E, Monte W 1994 Brain Damage in the Preterm Infant. MacKeith Press, London, 119–137.
Rypens F, Avni EF, Dussaussois L, David P, Vermeylen D, Van Bogaert P, Matos C 1994 Hyperechoic thickened ependyma: sonographic demonstration and significance in neonates. Pediatr Radiol 24: 550–553.
Kasper M, Goertchen R, Stosiek P, Perry G, Karsten U 1986 Coexistence of cytokeratin, vimentin and neurofilament protein in human choroid plexus. An immunohistochemical study of intermediate filaments in neuroepithelial tissues. Virchows Arch A Pathol Anat Histopathol 410: 173–177.
Blennow M, Rosengren L, Jonsson S, Forssberg H, Katz-Salamon M, Hagberg H, Hesser U, Lagercrantz H 1996 Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr 85: 485–489.
Fukumizu M, Takashima S, Becker LE 1995 Neonatal posthemorrhagic hydrocephalus: neuropathologic and immunohistochemical studies. Pediatr Neurol 13: 230–234.
Iida K, Takashima S, Takeuchi Y, Ohno T, Ueda K 1993 Neuropathologic study of newborns with prenatal-onset leukomalacia. Pediatr Neurol 9: 45–48.
Gilles FH, Leviton A, Kerr CS 1976 Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci 27: 183–191.
Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW 1994 Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14: 846–856.
Deguchi K, Mizoguchi M, Takashima S 1996 Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 14: 13–16.
Chao CC, Hu S, Sheng WS, Peterson PK 1995 Tumor necrosis factor-α production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 17: 97–105.
Lee SC, Dickson DW, Liu W, Brosnan CF 1993 Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ. J Neuroimmunol 46: 19–24.
Chao CC, Hu S, Ehrlich L, Peterson PK 1995 Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N- methyl-D-aspartate receptors. Brain Behav Immun 9: 355–365.
Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA 1988 Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81: 1162–1172.
Peterson PK, Hu S, Anderson WR, Chao CC 1994 Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 170: 457–460.
Hattori H, Wasterlain CG 1990 Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity. Pediatr Neurol 6: 219–228.
McDonald JW, Johnston MV 1990 Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 15: 41–70.
Hagberg H, Gilland E, Bona E, Hanson LÅ, Hahn-Zoric M, Blennow M, Holst M, McRae A, Söder O 1996 Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 40: 603–609.
Romero R, Tartakovsky B 1992 The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 167: 1041–1045.
Shi Y, Li HQ, Chen CK, Wang JH, Pan J, Qin SW, Liu R 1993 Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection. Pediatr Res 34: 345–348.
Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hanson LÅ 1996 Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr Res 40: 257–262.
Author information
Authors and Affiliations
Additional information
Supported by National Institute for Neurologic Disorders and Stroke Grant NS 27306.
Rights and permissions
About this article
Cite this article
Dammann, O., Leviton, A. Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn. Pediatr Res 42, 1–8 (1997). https://doi.org/10.1203/00006450-199707000-00001
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199707000-00001
This article is cited by
-
Maternal and neonatal outcomes following magnesium sulfate in the setting of chorioamnionitis: a meta-analysis
Archives of Gynecology and Obstetrics (2023)
-
Association between history of miscarriage and autism spectrum disorder
European Archives of Psychiatry and Clinical Neuroscience (2023)
-
Visuopathy of prematurity: is retinopathy just the tip of the iceberg?
Pediatric Research (2022)
-
Early arterial pressure monitoring and term-equivalent age MRI findings in very preterm infants
Pediatric Research (2022)
-
Microglia and Stem-Cell Mediated Neuroprotection after Neonatal Hypoxia-Ischemia
Stem Cell Reviews and Reports (2022)